Canadian approval of IV cytomegalovirus (CMV) immune globulin for the attenuation of CMV infection Media release 20 February 2013 Pages: 22 - 22
Monoclonal antibody IDEC-C2B8 [rituximab] has been recommended for US approval News item 20 February 2013 Pages: 22 - 22
A US FDA committee has recommended that filgrastim be approved for patients with acute myeloid leukaemia News item 20 February 2013 Pages: 23 - 23